RNAZ
Transcode Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.71
−0.58%Next report
Analyst consensus
- Next report date
- Nov 18, 2026
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$7.17
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -63.9%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | — | -$7.17 | — | — |
| May 15, 2026 | — | -$21 | — | — |
| Nov 14, 2025 | -$9.24 | -$5.49 | Beat 40.58% | — |
| Aug 14, 2025 | -$8.68 | -$4.94 | Beat 43.09% | — |
| May 14, 2025 | -$3.21 | -$17 | Miss -423.68% | — |
| Mar 28, 2025 | -$106 | -$17 | Beat 84.32% | — |
| Nov 14, 2024 | -$16 | -$5.28 | Beat 67.35% | — |
| Aug 14, 2024 | -$19 | -$24 | Miss -27.59% | — |
| May 15, 2024 | -$23 | -$21 | Beat 7.14% | — |
| Nov 14, 2023 | -$2.0K | -$2.2K | Miss -12.00% | — |
| Aug 14, 2023 | -$4.5K | -$4.3K | Beat 2.95% | — |
| Mar 31, 2023 | -$10.0K | -$10.3K | Miss -2.63% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 18, 2026